tiprankstipranks
Trending News
More News >
Alterity Therapeutics Ltd. (AU:ATH)
OTHER OTC:ATH

Compare Alterity Therapeutics (ATH) vs. Competitors

Compare
33 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Alterity Therapeutics
AU$0.01
AU$87.00M
-5.26
0.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Imugene
AU$0.33
AU$107.13M
-1.04
-75.74%
0 Buy
0 Hold
0 Sell
Moderate Buy
Paradigm Biopharmaceuticals
AU$0.33
AU$145.21M
-6.74
-26.37%
EZZ Life Science Holdings Ltd.
AU$1.45
AU$84.21M
12.28
-17.75%
Recce Pharmaceuticals Ltd.
AU$0.41
AU$202.43M
-7.66
48.39%
Arovella Therapeutics Limited
AU$0.08
AU$106.91M
-12.94
-53.68%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:ATH
Alterity Therapeutics
0.01
>-0.01
-44.44%
AU:IMU
Imugene
0.33
-1.06
-76.33%
AU:PAR
Paradigm Biopharmaceuticals
0.34
-0.13
-27.17%
AU:EZZ
EZZ Life Science Holdings Ltd.
1.97
-0.23
-10.40%
AU:RCE
Recce Pharmaceuticals Ltd.
0.69
0.22
48.39%
AU:ALA
Arovella Therapeutics Limited
0.09
-0.09
-51.11%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts